Octreotide for treatment of postoperative chylothorax

J Pediatr. 2001 Jul;139(1):157-9. doi: 10.1067/mpd.2001.115572.

Abstract

Two infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid.

Publication types

  • Case Reports

MeSH terms

  • Chylothorax / drug therapy*
  • Female
  • Heart Defects, Congenital / surgery
  • Hormones / administration & dosage
  • Hormones / therapeutic use*
  • Humans
  • Infant
  • Injections, Subcutaneous
  • Male
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Pleural Effusion / metabolism
  • Postoperative Complications / drug therapy*

Substances

  • Hormones
  • Octreotide